Naltrexone belongs to a class of drugs known as opioid antagonists. Naltrexone blocks opiate drugs from binding to the opioid receptors, which can result in increased endorphin and enkephalin release. Therefore, this results in reduced: 1. signaling and release of inflammatory substances, 2. nerve cell inflammation and 3. autoimmune mediators.
Would you like to hear some words of wisdom from a pain management physician we work with, about LDN in medical practice?
You can request access to the in-depth, 1 hour video presentation on Low Dose Naltrexone (LDN) in medical practices from an expert physician.
Exclusive to Medical Providers
• Down regulates inflammatory cytokine release, oncogene expression and auto-immune cascades
• In the Central Nervous System (CNS) it reduces toll-like receptor signaling and glial cell activation resulting in reduced inflammatory cytokines and reduced neuro-inflammation
• In the Peripheral Nervous System (PNS) it modulates T & B lymphocyte production (example: gut inflammation), and reduces inflammatory cytokines (IL6, IL12, TNF alpha) and suppresses tumor growth factor (NF-kB)
When taken at bedtime, the short acting LDN binds to the receptors which leads to a brief blockade of opioid receptors between 2 am and 4 am. This blockade is believed to up-regulate vital elements of the immune system by causing an increase in endorphin and enkephalin production.
John Herr, PCCA Advisory Council, Owner of T&C Compounding Pharmacy
Expert Pharmacist John Herr, RPh has worked with researchers, physicians, and patients worldwide to become an expert in proper titrations & dosage of Low Dose Naltrexone (LDN).
He has observed its multiple treatment benefits for chronic pain & various autoimmune conditions.
Town & Country Compounding remains dedicated to LDN research. We continue to uphold high standards in providing quality customized medication to our community.
T&C Compounding works with the most prestigious providers. We work with you and health providers/specialists to formulate the most customized medication regimens to fit your specific needs. Medication is not one-size-fits-all, our compounding specialists use precise compounding techniques & equipment to get you the best solution.
It’s important to ask questions when researching medications, especially when it comes to pain relief. Many individuals looking for alternatives to addictive opioids have found Low Dose Naltrexone (LDN) can be the solution. T&C Compounding’s John Herr, RPh., has become a national expert by studying and connecting with global experts in LDN, and has helped a vast amount of patients get through chronic pain. Contact T&C to get more info.
Find the right LDN Dosage Form for your specific needs & preferences.
The titration kit enables a patient to start their low dose naltrexone therapy and slowly ease into the dose that is appropriate for them. Kit determines personal effective dose, or maintenance dose that is right for the patient.
Taking LDN in oral capsules by mouth is the most cost-effective means of administering naltrexone and it’s the one we see most commonly prescribed. The capsules may be compounded lactose free & specific allergens can be avoided upon request.
Naltrexone in a liquid may be prescribed for patients who may have a hard time swallowing oral capsules or for patients who may have to adjust their dose quite often or who have not yet found their perfect dose. Flavored to preference.
Some medical conditions require the topical administration of naltrexone alone or in combination with other active pharmaceutical ingredients (API’s). LDN is compounded into elegant topical cream bases that are non-irritating for the patient.
Certain medical conditions may require LDN to be administered by itself or in combination with another drug in a vaginal cream or gel.
Vaginal Applicator for LDN administrating with detailed instructions included.
Finding solutions for chronic pain & autoimmune conditions can be a difficult process. Share your positive experience of Low Dose Naltrexone (LDN) with others that are considering and researching non-opioid options. Hearing real-life results from real patients & providers can give individuals the confidence they need.
T&C Compounding holds regular seminars connecting patients & providers with newest advancements in utilizing LDN for Chronic Pain & Autoimmune Conditions. We are always welcoming patients that have found success to share their stories with the community. We encourage you to share with individuals that may be suffering, so that they may find the relief they are looking for.
Would you like to speak about your positive experience at one of our upcoming LDN Seminars? We’d love to have you!
Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease,multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells.
This review covers the typical usage of LDN in clinical trials, caveats to using the medication, and recommendations for future research and clinical work. LDN may represent one of the first glial cell modulators to be used for the management of chronic pain disorders.
Get insight from providers that prescribe Low Dose Naltrexone (LDN) for their patients.
Board Certified Physician Specializing in Pain Management and Opioid Detox
Find the right dosage for YOU. Owner and expert pharmacist John Herr, RPh explains how T&C’s LDN Titration Kit provides you the most ideal dosage strength appropriate to yield the results you desire. We work with you, along with your physician to get the relief you need.
Dr. Westin Childs is dedicated to helping people with thyroid problems and hormonal imbalances in fining a solution. He is focused on personalized and functional medicine and has practiced in treating Hypothyroidism, Insulin resistance, and Leptin resistance. In this video, Dr. Westin Childs explains 6 ways Naltrexone (LDN) helps with weight loss and who should consider using it.
Recently, NBC News released a fascinating report linking central nervous system inflammation and Alzheimer’s. If true, is the first truly “attackable” angle to help prevent and potentially mitigate the symptoms of Alzheimer’s.
This could hold opportunities to advance and focus medication development towards neuroinflammation.
Low Dose Naltrexone (LDN), may be exceptionally good at reducing neuroinflammation, to the point where it could accomplish symptom reductions for neurological diseases and conditions that aren’t possible with other medications.
